Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Brii Biosciences Limited ( (HK:2137) ) just unveiled an announcement.
Brii Biosciences Limited announced that its board of directors will hold a meeting on August 21, 2025, to consider and approve the company’s unaudited interim results for the first half of the year. This meeting is significant as it will provide insights into the company’s financial health and operational progress, potentially impacting its market positioning and stakeholder confidence.
The most recent analyst rating on (HK:2137) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on Brii Biosciences Limited stock, see the HK:2137 Stock Forecast page.
More about Brii Biosciences Limited
Brii Biosciences Limited is a biotechnology company incorporated in the Cayman Islands, focusing on developing innovative therapies for infectious diseases and other significant health challenges.
YTD Price Performance: 100%
Average Trading Volume: 4,943,258
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.43B
For a thorough assessment of 2137 stock, go to TipRanks’ Stock Analysis page.